Related Experiment Video
Updated: Jul 17, 2026

An Affordable HIV-1 Drug Resistance Monitoring Method for Resource Limited Settings
Published on: March 30, 2014
Viability of HIV-1 in syringes: implications for interventions among injection drug users
1Department of Epidemiology and Public Health, Yale University School of Medicine, New Haven, Conn., USA.
Abstract:
We have determined that the duration of survival of HIV-1 in syringes typically used by injectors of illicit drugs can exceed 6 weeks. The percentage of syringes with viable virus varied with the volume of blood remaining in the syringes and the temperature at which syringes were stored. These experiments underscore the need for needle exchange programs and other HIV prevention interventions that promote the availability of clean syringes and the removal of potentially infectious ones from circulation.
Related Concept Videos
Retrovirus Life Cycles
Immunodeficiency Diseases
There are three main causes of immunodeficiency disorders...
Sexually Transmitted Infections
Pulmonary Tuberculosis I
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Inhibitors of Virion Maturation and Assembly

